Delivery Order SPE2DR25D2006-SPE2DR26F57BX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Adderall 10 mg tablets in quantities of 100 units, with a ceiling value of $1,225.66. This firm fixed-price delivery order is set to be completed by December 12, 2025, and represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets in quantities of 100 units, with a ceiling value of $1,838.49. This competitive award, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, utilizes firm fixed pricing and carries no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,985.64 to AmerisourceBergen Drug Corp for the supply of Adderall tablets (30 mg) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,838.49 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall 10 mg tablets in quantities of 100. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a non-competitive set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $31,115.81 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Adderall 10 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to a qualified pharmaceutical vendor. The contract is scheduled for ultimate completion on December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Adderall 10 mg tablets in quantities of 100 units, with a ceiling value of $1,899.03. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Adderall 20 mg tablets in quantities of 100, with a ceiling value of $4,902.64. This firm fixed-price delivery order, with an ultimate completion date of December 12, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Adderall 10 mg tablets in quantities of 100, with a ceiling value of $3,012.75 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Adderall 10 mg tablets in quantities of 100, with a ceiling value of $7,054.28. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the federal medical supply chain. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100-count) on October 27, 2025, with a ceiling value of $2,451.32 and an ultimate completion date of October 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is listed as Conshohocken, Pennsylvania, where...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57BXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Adderall 10 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $9,850.72 with a firm fixed price structure and an ultimate completion date of January 6, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor to the Defense Logistics Agency, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and federal healthcare systems worldwide. The company's extensive federal procurement portfolio demonstrates its capacity to fulfill diverse pharmaceutical needs across multiple therapeutic domains, including neurological treatments, diabetes medications, pain management drugs, and specialized medical commodities that serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 1/4/26 |